Diagnostics of anemia and iron deficiency in patients with chronic heart failure
DOI:
https://doi.org/10.26641/2307-0404.2023.1.276007Ключові слова:
anemia, iron deficiency, chronic heart failure, diagnosticsАнотація
According to the recommendations of the European Society of Cardiology (ESC) 2021 for the management of patients with chronic heart failure (CHF), it is necessary to take into account the iron level in the diagnosis of all patients with firstly diagnosed heart failure (HF). Also the practical recommendations indicate that the assessment of iron deficiency is also carried out in patients with already confirmed CHF, especially if the symptoms of HF persist against the background of optimal treatment of the underlying disease, which necessitates knowledge of the diagnosis of anemia and iron deficiency in patients with CHF. The aim was review literature illustrating current data about diagnostics of iron deficiency and anemia in patients with CHF. In the work 28 sources from the Web of Science database and 7 sources from the PubMed database were analyzed. Anemia is diagnosed by hemoglobin levels. As criteria for iron deficiency, two parameters are used in clinical practice – ferritin level and transferrin saturation. The mean corpuscular volume of erythrocytes and the mean hemoglobin content in them were not reliable markers of iron deficiency and are not recommended for assessing iron deficiency in patients with HF. Depletion of iron stores in the bone marrow is a highly specific for iron deficiency, as it is not affected by inflammation and therefore the test for iron stores in the bone marrow is the gold standard for diagnosis, however its use in clinical practice is limited due to invasiveness and high cost. Diagnostic markers such as levels of hepsidin, dissolved transferrin receptor and ferritin index have low availability in laboratories. Since timely diagnosis followed by treatment of anemia and iron deficiency in patients with CHF impoves the quality of life of patients, therefore, increasing the diagnostic value of tests to identify iron deficiency remains a question for active research.
Посилання
Dollina OV. [Pathogenesis and ways of correction of anem syndrome in patients with chronic heart failure]. Simeyna medycina. 2016;1:58-62. Ukrainian. doi: https://doi.org/10.30841/2307-5112.1(63).2016.102096
Ettinger OA. [Anemia in patients with chronic heart failure: the role of iron deficiency and its correction]. Consilium medicum. 2013;5:121-7. Russian.
Gilyarevskiy SR. [Anemia in patients with chronic heart failure: current state of the problem]. Russian Sklifosovsky Journal of Emergency Medical Care. 2019;1:68-73. Russian. doi: https://doi.org/10.23934/2223-9022-2019-8-1-68-73
Ivanov VP. [The problem of treating anemia in patients with chronic heart failure]. Medicni perspektivi. 2018;1:34-43. Ukrainian. doi: https://doi.org/10.26641/2307-0404.2018.1(part2).126939
Smirnova MP. [Anemia anf iron deficiency in patients with chronic heart failure]. Vestnik Ivanovskoy medicinskoy akademii. 2018;1:12-6. Russian. Available from: https://cyberleninka.ru/article/n/anemiya-i-defitsit-zheleza-u-bolnyh-s-serdechnoy-nedostatochnostyu
Smirnova MP. [Iron deficiency associations in patients with chronic heart failure]. Vestnik of modern clinical medicine. 2021;14:27-34. Russian. doi: https://doi.org/10.20969/VSKM.2021.14(4).27-34
Anand IS, Gupta P. Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies. Circulation. 2018;138(1):80-98. doi: https://doi.org/10.1161/circulationaha.118.030099
Archer NM, Brugnara C. Diagnosis of iron-deficient states. Crit Rev Clin Lab Sci. 2015;52(5):256-72. doi: https://doi.org/10.3109/10408363.2015.1038744
Cappellini MD, Comin-Colet J, de Francisco A, Dignass A, Doehner WS, Lam C, et al. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management. Am J Hematol. 2017;92(10):1068-78. doi: https://doi.org/10.1002/ajh.24820
Camaschella C. Iron deficiency. Blood. 2019;133(1):30-9. doi: https://doi.org/10.1182/blood-2018-05-815944
Cohen-Solal A, Leclercq C, Mebazaa A, De Groote P, Damy T, Isnard R, et al. Diagnosis and treatment of iron deficiency in patients with heart failure: Expert position paper from French cardiologists. Arch Cardiovasc Dis. 2014;107(10):563-71. doi: https://doi.org/10.1016/j.acvd.2014.07.049
Cullis JO. Diagnosis and management of anaemia of chronic disease: current status. Br J Haematol. 2011;154(3):289-300. doi: https://doi.org/10.1111/j.1365-2141.2011.08741.x
DÍez-López C, Comín-Colet J, González-Costel-lo J. Iron overload cardiomyopathy: From diagnosis to management. 2018;33(3):334-40. doi: https://doi.org/10.1182/blood-2018-05-815944
Díez-López C, Lupón J, de Antonio M, Za-mora E, Domingo M, Santesmases J, et al. Hemoglobin Kinetics and Long-term Prognosis in Heart Failure. Rev Española Cardiol (English Ed.) 2016;69(9):820-6. doi: https://doi.org/10.1016/j.rec.2016.02.028
Ding H, Yu X, Feng J. Iron homeostasis disorder in piglet intestine Metallomics. 2020;21,12(10):1494-507. doi: https://doi.org/10.1039/d0mt00149j
Gaweda AE. Markers of iron status in chronic kidney disease. Hemodial Int. 2017;21:S21-7. doi: https://doi.org/10.1111/hdi.12556
Gkouvatsos K, Papanikolaou G, Pantopoulos K. Regulation of iron transport and the role of transferrin. Biochim et Bioph Acta - Gen Subj. 2012;1820(3):188-202. doi: https://doi.org/10.1016/j.bbagen.2011.10.013
Gonzalez-Costello J, et al. Use of intravenous iron in patients with iron deficiency and chronic heart failure: Real-world evidence. Eur J of Med. 2020;80:91-8. doi: https://doi.org/10.1016/j.ejim.2020.04.031
Moe GW, Ezekowitz JA, O'Meara E, Lepage S, Howlett JG, Fremes S, et al. The 2014 Canadian Cardio-vascular Society Heart Failure Management Guidelines Focus Update: Anemia, Biomarkers, and Recent Therapeutic Trial Implications. Can J Cardiol. 2015:31(1):3-16. doi: https://doi.org/10.1016/j.cjca.2014.10.022
Grote Beverborg N, van Veldhuisen DJ, van der Meer P. Anemia in Heart Failure: Still Relevant? JACC Hear Fail. 2018;6(3):201-8. doi: https://doi.org/10.1016/j.jchf.2017.08.023
Jankowska EA, Rozentryt P, Witkowska A, No-wak J, Hartmann O, Ponikowska B, et al. Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure. J Card Fail. 2011;17(11):899-906. doi: https://doi.org/10.1016/j.cardfail.2011.08.003
Jankowska EA, Von Haehling S, Anker SD, MacDougall IC, Ponikowski P. Iron deficiency and heart failure: Diagnostic dilemmas and therapeutic perspectives. Eur Heart J. 2013;34(11):816-26. doi: https://doi.org/10.1093/eurheartj/ehs224
Jankowska EA, Suchocki T, Tkaczyszyn M, Von Haehling S, Doehner W, Banasiak W, et al. Effects of Intravenous Iron Therapy in Iron Deficient Patients With Systolic Heart Failure: Meta-Analysis of Randomized Control Trials. J Am Coll Cardiol. 2015;65(10):A854. doi: https://doi.org/10.1002/ejhf.473
Magrì D, et al. Anemia and Iron Deficiency in Heart Failure: Clinical and Prognostic Role. Heart Fail. Clin. 2019;15(3):359-69. doi: https://doi.org/10.1016/j.hfc.2019.02.005
McDonagh T, Damy T, Doehner W, Lam CS, Sindone A, van der Meer P, et al. Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice. Eur J Heart Fail. 2018;20(12):1664-72. doi: https://doi.org/10.1002/ejhf.1305
Muñoz M, Acheson AG, Auerbach M, Besser M, Habler O, Kehlet H, et al. International consensus state-ment on the peri-operative management of anaemia and iron deficiency. Anaesthesia. 2017;72(2):233-47. doi: https://doi.org/10.1111/anae.13773
Musallam KM, Taher AT. Iron deficiency beyond erythropoiesis: should we be concerned? Curr Med Res Opin. 2018;34(1):81-93. doi: https://doi.org/10.1080/03007995.2017.1394833
Nanas JN, et al. Etiology of Anemia in Patients With Advanced Heart Failure. J Am Col Card. 2006;48(12):2485-9. doi: https://doi.org/10.1016/j.jacc.2006.08.034
Paolillo S, Scardovi AB, Campodonico J. Role of comorbidities in heart failure prognosis. Part I: Anaemia, iron deficiency, diabetes, atrial fibrillation. Eur J of Prevent Cardio. 2020;27(2):27-34. doi: https://doi.org/10.1177/2047487320960288
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure As¬sociation (HFA) of the ESC. Eur Heart J. 2021;42(36):3599-726. doi: https://doi.org/10.1093/eurheartj/ehab368
Rishi G, Wallace DF, Subramaniam VN. Hepcidin: regulation of the master iron regulator. Biosci Rep. 2015;35(3):e00192. doi: https://doi.org/10.1042/BSR20150014
Sîrbu O, et al. Anemia in heart failure- from guidelines to controversies and challenges. Anatol J of Cardio. 2018;20(1):52-9. doi: https://doi.org/10.14744/AnatolJCardiol.2018.08634
Tkaczyszyn M, Jankowska EA. Iron deficiency and red cell indices in patients with heart failure: reply. Eur J Heart Fail. 2018;20(4):828-9. doi: https://doi.org/10.1002/ejhf.1092
Von Haehling S, Jankowska EA, Van Vel-dhuisen DJ, Ponikowski P, Anker SD. Iron deficiency and cardiovascular disease. Nat Rev Cardiol. 2015;12(11):659-69. doi: https://doi.org/10.1038/nrcardio.2015.109
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Colvin MM, et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017 Aug 8;136(6):e137-61. doi: https://doi.org/10.1161/cir.0000000000000509
##submission.downloads##
Опубліковано
Як цитувати
Номер
Розділ
Ліцензія
Авторське право (c) 2023 Медичні перспективи
Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.